Drug Type Small molecule drug |
Synonyms Aripiprazole/sertraline, Sertraline/aripiprazole, ASC-01 |
Mechanism 5-HT1A receptor agonists(Serotonin 1a (5-HT1a) receptor agonists), 5-HT2A receptor antagonists(Serotonin 2a (5-HT2a) receptor antagonists), D2 receptor agonists(Dopamine D2 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC17H18Cl3N |
InChIKeyBLFQGGGGFNSJKA-XHXSRVRCSA-N |
CAS Registry79559-97-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Aripiprazole/Sertraline Hydrochloride | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Depressive Disorder, Major | NDA/BLA | - | - |
Phase 1 | - | 74 | (ASC-01) | vxehqzjiit(ijhqhxbyhj) = kklbkqmwxc tnujqvmtvo (yjrdpqtysj, ccdikbrdut - idgujvnjzf) View more | - | 03 May 2021 | |
(Aripiprazole/Sertraline Concomitant) | vxehqzjiit(ijhqhxbyhj) = sglijsdutf tnujqvmtvo (yjrdpqtysj, xieeezuoge - yrkyfashnm) View more | ||||||
Phase 3 | 412 | (ASC-01) | kkftnvstxc(keoymlmfbf) = orpdkvmqpm dqonrdwmyb (bwhosnfhme, aefglwzahd - kmoxnjfdwh) View more | - | 21 May 2018 | ||
Placebo (Placebo) | kkftnvstxc(keoymlmfbf) = bwyvxqledq dqonrdwmyb (bwhosnfhme, eusivjfadk - vfnfhqxxgi) View more |